Fund Strategy
EMBL Ventures is an independent venture capital investor that engages in the financing and development of first-in-class products and technologies in the healthcare sector. Based on a strong scientific pedigree, the Fund strategy combines the core competencies of "Pharma" and "Biotech" to arrive at a scalable investment model that seeks at creating commercial value.
"The EMBL Ventures team stands out through its professional competence, loyalty, consistency and intense interest in the development of Fibrex. As a consequence, convincing solutions are found in a timely fashion, even in difficult situations. EMBL Ventures offers access to its broad scientific and industry network, which is a tremendous support to achieve our company goals."
Dr. Rainer Henning; CEO, Fibrex Medical, Vienna